Kidney Cancer Session from the NCCN 2010 Congress Series, Genitourinary Cancers™ - NCCN Educational Opportunities

Educational Events & Programs
Live Webcast: Kidney Cancer Session from the NCCN 2010 Congress Series, Genitourinary Cancers™
Monday, October 18, 2010 (On-line Webinar)
12:45 PM – 5:00 PM CDT
Register now to secure a seat at this educational activity.

Program Overview:

This live educational webcast is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines™ for Kidney Cancers. Participants will learn how to implement the recommendations within the NCCN Guidelines into their practice and gain a clear understanding of the most up-to-date treatment recommendations for kidney cancer. The content presented will be supported by case studies.

On area of discussion during this live webcast will be on targeted therapies. While cytokines have been the standard of care for many years, recent developments in targeted therapies are improving patient outcomes, progression-free survival, quality of life, and, at times, overall survival.

Educational Objectives:

Following this program, participants should be able to:

* Identify the appropriate evaluation techniques for kidney cancer diagnosis and staging
* Summarize the role of surgical management in localized and resectable advanced kidney cancer
* Describe the role of cytokine therapy and targeted therapies in unresectable and recurrent kidney cancer


Intended Audience:

This educational program is designed to meet the educational needs of oncologists, urologists, nurses, pharmacists, and other health care professionals who manage patients with kidney cancer.

Tentative Agenda:

KIDNEY CANCER

12:45 - 1:30 PM


Initial Evaluation, Diagnosis, and Staging of Kidney Cancer
Sam S. Chang, MD
Vanderbilt-Ingram Cancer Center

1:35 – 2:20 PM


Surgical Management of Localized Kidney Cancer and Resectable Advanced Disease
Benjamin I. Chung, MD
Stanford Comprehensive Cancer Center

2:20 - 2:40 PM


Break and Exhibits

2:40 - 3:25 PM


Targeted Therapy Options in Unresectable and Recurrent Kidney Cancer
Robert J. Motzer, MD
Memorial Sloan-Kettering Cancer Center

3:30 - 3:50 PM


Case Presentation: Management of Advanced Kidney Cancer
Ana Molina, MD
Memorial Sloan-Kettering Cancer Center

3:55 - 4:40 PM






The Role of Cytokine Therapy in Unresectable or Recurrent Kidney Cancer
Kim A. Margolin, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
4:45 – 5:00 PM Closing Remarks

Accreditation:
Physicians
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCCN designates this educational activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses

This activity is approved for 3.25 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Pharmacist Continuing Education

Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 3.25 contact hour(s) (0.325 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number TBD)

Fee Information
There is no fee for this educational activity. In order to receive a statement of credit, participants will need to attend the educational activity and complete the evaluation form. Partial credit will not be awarded. Statements of credit will be mailed within 4 to 6 weeks of the meeting. Pharmacists should note that they must attend the entire activity to be eligible for credit.

Faculty Disclosure
All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.>/p>

Supporters:
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, LP; Centocor Ortho Biotech; Genentech; Novartis Oncology; Pfizer; and sanofi-aventis.
Register now to secure a seat at this educational activity.
NCCN Educational Opportunities